NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 3 filers reported holding NATERA INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $44,250 | -9.1% | 1,000 | 0.0% | 0.02% | -7.4% |
Q2 2023 | $48,660 | -12.4% | 1,000 | 0.0% | 0.03% | -15.6% |
Q1 2023 | $55,520 | +38.2% | 1,000 | 0.0% | 0.03% | +28.0% |
Q4 2022 | $40,170 | -8.7% | 1,000 | 0.0% | 0.02% | -16.7% |
Q3 2022 | $44,000 | +25.7% | 1,000 | 0.0% | 0.03% | +30.4% |
Q2 2022 | $35,000 | -14.6% | 1,000 | 0.0% | 0.02% | -4.2% |
Q1 2022 | $41,000 | -55.9% | 1,000 | 0.0% | 0.02% | -55.6% |
Q4 2021 | $93,000 | -16.2% | 1,000 | 0.0% | 0.05% | -25.0% |
Q3 2021 | $111,000 | -2.6% | 1,000 | 0.0% | 0.07% | -10.0% |
Q2 2021 | $114,000 | +11.8% | 1,000 | 0.0% | 0.08% | +5.3% |
Q1 2021 | $102,000 | +2.0% | 1,000 | 0.0% | 0.08% | -15.6% |
Q4 2020 | $100,000 | – | 1,000 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 881,436 | $48,937,327 | 32.36% |
Kynam Capital Management, LP | 2,918,237 | $162,020,518 | 20.92% |
Sofinnova Investments, Inc. | 3,100,560 | $172,143,091 | 11.01% |
Eversept Partners, LP | 2,819,770 | $156,553,630 | 10.92% |
Eagle Health Investments LP | 784,894 | $43,577,315 | 8.48% |
Lagoda Investment Management, L.P. | 162,625 | $9,028,940 | 6.42% |
BEACONLIGHT CAPITAL, LLC | 204,567 | $11,357,560 | 6.00% |
Bain Capital Life Sciences Investors, LLC | 700,197 | $38,875 | 4.86% |
PERKINS CAPITAL MANAGEMENT INC | 62,700 | $3,481 | 3.28% |
RTW INVESTMENTS, LP | 2,611,783 | $145,006,192 | 3.02% |